Lv11
60 积分 2023-12-03 加入
Which Modality of SFRT Should be Considered First for Bulky Tumor Radiation Therapy, GRID or LATTICE
2小时前
待确认
A journey to understand SFRT
2小时前
已完结
Aumolertinib with or without chemotherapy in EGFR-mutated advanced non-small-cell lung cancer (AENEAS2): an open-label, multicentre, randomised, controlled, phase 3 trial
1个月前
已完结
皖公网安备34019202002308
